These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 16517694)

  • 21. Viral induced demyelination.
    Stohlman SA; Hinton DR
    Brain Pathol; 2001 Jan; 11(1):92-106. PubMed ID: 11145206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system.
    Cuzner ML; Opdenakker G
    J Neuroimmunol; 1999 Feb; 94(1-2):1-14. PubMed ID: 10376931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Animal models for autoimmune demyelinating disorders of the nervous system.
    Gold R; Hartung HP; Toyka KV
    Mol Med Today; 2000 Feb; 6(2):88-91. PubMed ID: 10652482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mitochondrial DNA Double-Strand Breaks in Oligodendrocytes Cause Demyelination, Axonal Injury, and CNS Inflammation.
    Madsen PM; Pinto M; Patel S; McCarthy S; Gao H; Taherian M; Karmally S; Pereira CV; Dvoriantchikova G; Ivanov D; Tanaka KF; Moraes CT; Brambilla R
    J Neurosci; 2017 Oct; 37(42):10185-10199. PubMed ID: 28931570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammatory demyelinating diseases of the central nervous system.
    Höftberger R; Lassmann H
    Handb Clin Neurol; 2017; 145():263-283. PubMed ID: 28987175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic central nervous system demyelination in mice after JHM virus infection.
    Stohlman SA; Weiner LP
    Neurology; 1981 Jan; 31(1):38-44. PubMed ID: 6256683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Experimental allergic encephalomyelitis as an animal model for multiple sclerosis].
    Lukinović-Skudar V; Taradi SK; Andreis I; Zupancić V; Taradi M
    Lijec Vjesn; 2001; 123(3-4):81-8. PubMed ID: 11488222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-level laser therapy ameliorates disease progression in a mouse model of multiple sclerosis.
    Gonçalves ED; Souza PS; Lieberknecht V; Fidelis GS; Barbosa RI; Silveira PC; de Pinho RA; Dutra RC
    Autoimmunity; 2016; 49(2):132-42. PubMed ID: 26703077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Demyelination and autoimmunity].
    Lebar R
    Pathol Biol (Paris); 1987 Mar; 35(3):275-83. PubMed ID: 3295694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of Mast Cells in the Pathogenesis of Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis.
    Elieh-Ali-Komi D; Cao Y
    Clin Rev Allergy Immunol; 2017 Jun; 52(3):436-445. PubMed ID: 28025778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pathogenesis of multiple sclerosis and other neural autoimmune diseases].
    Lassmann H
    Verh Dtsch Ges Pathol; 1996; 80():109-15. PubMed ID: 9064993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contrasting roles for axonal degeneration in an autoimmune versus viral model of multiple sclerosis: When can axonal injury be beneficial?
    Tsunoda I; Tanaka T; Terry EJ; Fujinami RS
    Am J Pathol; 2007 Jan; 170(1):214-26. PubMed ID: 17200195
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clonal expansion of infiltrating T cells in the spinal cords of SJL/J mice infected with Theiler's virus.
    Kang JA; Mohindru M; Kang BS; Park SH; Kim BS
    J Immunol; 2000 Jul; 165(1):583-90. PubMed ID: 10861099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RON-regulated innate immunity is protective in an animal model of multiple sclerosis.
    Tsutsui S; Noorbakhsh F; Sullivan A; Henderson AJ; Warren K; Toney-Earley K; Waltz SE; Power C
    Ann Neurol; 2005 Jun; 57(6):883-95. PubMed ID: 15929040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasminogen Activator Inhibitor-1 Antagonist TM5484 Attenuates Demyelination and Axonal Degeneration in a Mice Model of Multiple Sclerosis.
    Pelisch N; Dan T; Ichimura A; Sekiguchi H; Vaughan DE; van Ypersele de Strihou C; Miyata T
    PLoS One; 2015; 10(4):e0124510. PubMed ID: 25915660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Imaging evaluation of demyelinating processes of the central nervous system.
    Smith AB; Smirniotopoulos JG
    Postgrad Med J; 2010 Apr; 86(1014):218-29. PubMed ID: 20354045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An ultrastructural study of experimental demyelination and remyelination. 3. Chronic experimental allergic encephalomyelitis in the central nervous system.
    Prineas J; Raine CS; Wísniewski H
    Lab Invest; 1969 Dec; 21(6):472-83. PubMed ID: 5356782
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment with a recombinant human IgM that recognizes PSA-NCAM preserves brain pathology in MOG-induced experimental autoimmune encephalomyelitis.
    Lemus HN; Warrington AE; Denic A; Wootla B; Rodriguez M
    Hum Antibodies; 2017; 25(3-4):121-129. PubMed ID: 28269761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative ultrastructural analysis of a single spinal cord demyelinated lesion predicts total lesion load, axonal loss, and neurological dysfunction in a murine model of multiple sclerosis.
    Sathornsumetee S; McGavern DB; Ure DR; Rodriguez M
    Am J Pathol; 2000 Oct; 157(4):1365-76. PubMed ID: 11021839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduction of inflammation and preservation of neurological function by anti-CD52 therapy in murine experimental autoimmune encephalomyelitis.
    Turner MJ; Pang PT; Chretien N; Havari E; LaMorte MJ; Oliver J; Pande N; Masterjohn E; Carter K; Reczek D; Brondyk W; Roberts BL; Kaplan JM; Siders WM
    J Neuroimmunol; 2015 Aug; 285():4-12. PubMed ID: 26198912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.